Latest ACR News
-
A matched cohort study from the Veterans Health Administration shows that rheumatoid arthritis patients have a >50% increased risk of lung cancer, and a 3-fold higher risk of lung cancer in RA-interstitial lung disease (ILD).Read Article
Making Better Posters: Dr. David Liew
Dr. David Liew describes how some presenters are working to make their posters better design-wise to improve their presentation at the 2019 ACR/ARP annual meeting in Atlanta.
Romosozumab and Patients with Chronic Kidney Disease: Dr. Arthur Lau
Dr. Lau discusses abstract #2730 presented at the 2019 ACR/ARP annual meeting in Atlanta.
SJIA-associated ILD: Dr. Jonathan Hausmann
Dr. Hausmann describes a new inflammatory lung disease at the 2019 ACR/ARP annual meeting in Atlanta.
Lupus Pearls: Dr. Kathryn Dao
Dr. Dao reviews several lupus pearls presented by Dr. Michelle Petri at the 2019 ACR/ARP Annual Meeting in Atlanta.
Panel Presentation: Gout
Drs. Jack Cush, Nicola Dalbeth, Ken Saag, and Robert Keenan discuss key presentations related to gout presented at the 2019 ACR/ARP Annual Meeting in Atlanta.
Myosin Regulation May Contribute to Anti-TNF Therapy Response: Dr. Elaine Husni
Dr. Husni highlights abstract #1769 as presented at the 2019 ACR/ARP Annual Meeting in Atlanta.
Inflammatory Arthritis Persists After Immunotherapy Cessation: Dr. David Liew
Dr. Liew discusses abstract #1808 Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis Persists After Immunotherapy Cessation presented at the 2019 ACR/ARP Annual Meeting in Atlanta.
Studies on the Changing Face of RA: Dr. Janet Pope
Dr. Pope discusses abstract #171, #172 and #841 as presented at the 2019 ACR/ARP Annual Meeting in Atlanta.
Panel Presentation: Rheumatoid Arthritis
Drs. Jack Cush, Arthur Kavanaugh and Jonathan Kay discuss several rheumatoid arthritis studies presented at the 2019 ACR/ARP Annual Meeting in Atlanta. Abstracts discussed include abstract #1342, #1350, #1160, and more.
Drug Levels Associated with Lupus Flares: Dr. Janet Pope:
Dr. Pope discusses abstract #2567 Prospective Evaluation of American Academy of Ophthalmology Low Dose Hydroxychloroquine Recommendation in Stable Lupus Nephritis with High-Risk Retinopathy: Lipid Profile and Flare Rates presented at the 2019 ACR/ARP annual meeting in Atlanta.
Safety of Methotrexate (The CIRT Trial): Dr. Jack Cush
Dr. Cush discusses abstract #1890 on the CIRT trial as presented at the 2019 ACR/ARP annual meeting in Atlanta.
Dr. Dao talks with Dr. Gwenesta Melton about Women in Rheumatology
Dr. Dao interviews Dr. Melton about Women in Rheumatology
Social Media Professionalism: Dr. Michael Putman and Dr. Jilaine Bolek Berquist
Dr. Michael Putman talks with Dr. Jilaine Bolek Berquist about her talk on tweets and trolls in social media at the 2019 ACR/ARP annual meeting in Atlanta.
Domain Strategy and Treatment in Psoriatic Arthritis: Dr. Elaine Husni
Dr. Elaine Husni reviews her talk on domain strategies in PsA at the 2019 ACR/ARP annual meeting in Atlanta.
